1 | NELAS, NELAS2, PHGDH, PSAT1
|
| Neu-laxova syndrome is a heterogeneous metabolic disorder caused by defects in enzymes of the L-serine biosynthesis pathway.
|
| Acuna-Hidalgo R, Schanze D, Kariminejad A, Nordgren A, Kariminejad MH, Conner P, Grigelioniene G, Nilsson D, Nordenskjöld M, Wedell A, Freyer C, Wredenberg A, Wieczorek D, Gillessen-Kaesbach G, Kayserili H, Elcioglu N, Ghaderi-Sohi S, Goodarzi P, Setayesh H, van de Vorst M, Steehouwer M, Pfundt R, Krabichler B, Curry C, MacKenzie MG, Boycott KM, Gilissen C, Janecke AR, Hoischen A, Zenker M.
|
| Am J Hum Genet 95(3):285-93. doi: 10.1016/j.ajhg.2014.07.012. Epub 2014 Aug 21.
2014
|
2 | PSAT1
|
| PSAT1 regulates cyclin D1 degradation and sustains proliferation of non-small cell lung cancer cells.
|
| Yang Y, Wu J, Cai J, He Z, Yuan J, Zhu X, Li Y, Li M, Guan H.
|
| Int J Cancer nt J Cancer. 2014 Aug 21. doi: 10.1002/ijc.29150. [Epub ahead of print]
2014
|
3 | PHGDH, PRKCZ, PSAT1
|
| Control of nutrient stress-induced metabolic reprogramming by PKCζ in tumorigenesis.
|
| Ma L, Tao Y, Duran A, Llado V, Galvez A, Barger JF, Castilla EA, Chen J, Yajima T, Porollo A, Medvedovic M, Brill LM, Plas DR, Riedl SJ, Leitges M, Diaz-Meco MT, Richardson AD, Moscat J.
|
| Cell 152(3):599-611. doi: 10.1016/j.cell.2012.12.028.
2013
|
4 | PHGDH, PSAT1, PSATD, PSPH, PSPHD
|
| L-serine synthesis in the central nervous system: a review on serine deficiency disorders.
|
| Tabatabaie L, Klomp LW, Berger R, de Koning TJ.
|
| Mol Genet Metab 99(3):256-62. Epub 2009 Oct 25. Review.PMID: 19963421 2010
|
5 | PSAT1
|
| Recombinant production of eight human cytosolic aminotransferases and assessment of their potential involvement in glyoxylate metabolism.
|
| Donini S, Ferrari M, Fedeli C, Faini M, Lamberto I, Marletta AS, Mellini L, Panini M, Percudani R, Pollegioni L, Caldinelli L, Petrucco S, Peracchi A.
|
| Biochem J 422(2):265-72.PMID: 19545238 2009
|
6 | PSAT1
|
| Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cells.
|
| Vié N, Copois V, Bascoul-Mollevi C, Denis V, Bec N, Robert B, Fraslon C, Conseiller E, Molina F, Larroque C, Martineau P, Del Rio M, Gongora C.
|
| Mol Cancer 7:14.PMID: 18221502 2008
|
7 | PSATD, PSAT1
|
| Phosphoserine aminotransferase deficiency: a novel disorder of the serine biosynthesis pathway.
|
| Hart CE, Race V, Achouri Y, Wiame E, Sharrard M, Olpin SE, Watkinson J, Bonham JR, Jaeken J, Matthijs G, Van Schaftingen E.
|
| Am J Hum Genet 80(5):931-7. Epub 2007 Mar 30. 2007
|
8 | PSAT1
|
| Characterization of human phosphoserine aminotransferase involved in the phosphorylated pathway of L-serine biosynthesis.
|
| Baek JY, Jun do Y, Taub D, Kim YH.
|
| Biochem J 373(Pt 1):191-200. 2003
|
9 | PSAT1
|
| Phosphoserine aminotransferase, the second step-catalyzing enzyme for serine biosynthesis.
|
| Basurko MJ, Marche M, Darriet M, Cassaigne A.
|
| IUBMB Life 48(5):525-9. 1999
|
10 | PSAT1
|
| A novel progesterone-induced messenger RNA in rabbit and human endometria. Cloning and sequence analysis of the complementary DNA.
|
| Misrahi M, Atger M, Milgrom E.
|
| Biochemistry 26(13):3975-82. 1987
|